- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01211535
Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers
October 15, 2012 updated by: Alcon Research
The purpose of this study was to assess the comfort of OPTI-FREE RepleniSH in soft contact lens wearers.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
104
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Contact Alcon Trial Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Currently wearing silicone hydrogel contact lenses on a daily wear basis;
- Currently using OPTI-FREE RepleniSH contact lens solution;
- Generally healthy;
- Normal ocular health;
- Willing to follow study procedures and visit schedule;
- Sign Informed Consent and privacy document;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Use of additional lens cleaners;
- Known sensitivities to any ingredient in either test article;
- Systemic or ocular disease or disorder that would negatively affect the conduct or outcome of the study;
- History of ocular surgery/trauma within the last 6 months;
- Any topical ocular or systemic antibiotics within 7 days of enrollment continuing throughout the study;
- Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollent;
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: OPTI-FREE RepleniSH
OPTI-FREE RepleniSH multipurpose solution used with study contact lenses on a daily wear basis for 14 days
|
FDA-approved, multipurpose solution used as indicated for cleaning, rinsing, conditioning, disinfecting, and storing study contact lenses on a daily wear basis for 14 days
Other Names:
Silicone hydrogel contact lenses per subject's habitual brand and prescription worn on a daily wear basis for 14 days, with either OPTI-FREE RepleniSH or ReNu Biotrue used for contact lens care
|
Active Comparator: ReNu Biotrue
ReNu Biotrue multipurpose solution used with study contact lenses on a daily wear basis for 14 days
|
Silicone hydrogel contact lenses per subject's habitual brand and prescription worn on a daily wear basis for 14 days, with either OPTI-FREE RepleniSH or ReNu Biotrue used for contact lens care
FDA-approved, multipurpose solution used as indicated for cleaning, disinfecting, daily protein removing, and storing study contact lenses on a daily wear basis for 14 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline (Day 0) in Ocular Comfort Rating at Day 14
Time Frame: Baseline (Day 0), Day 14
|
Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable.
The participant marked a horizontal line across the scale at the point that best described, "how your eyes feel right now."
A positive number indicates increased ocular comfort; a negative number indicates decreased ocular comfort.
|
Baseline (Day 0), Day 14
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (Actual)
November 1, 2010
Study Completion (Actual)
November 1, 2010
Study Registration Dates
First Submitted
September 28, 2010
First Submitted That Met QC Criteria
September 28, 2010
First Posted (Estimate)
September 29, 2010
Study Record Updates
Last Update Posted (Estimate)
November 12, 2012
Last Update Submitted That Met QC Criteria
October 15, 2012
Last Verified
October 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMA-09-59
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Error
-
Alcon ResearchCompletedRefractive Error - Myopia Severe | Refractive Error - Myopia SimpleUnited States, Ireland, Singapore
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vision Service PlanCompletedRefractive Error - Myopia BilateralUnited States
-
Wang HongxiaTianjin Eye HospitalCompletedRefractive Error - Myopia AxialChina
-
Tianjin Eye HospitalRecruitingMyopia; Refractive ErrorChina
-
Abbott Medical OpticsCompletedStable Myopic Refractive Error, With or Without AstigmatismUnited States
-
KK Women's and Children's HospitalWithdrawnRefractive Error - Myopia
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
Clinical Trials on OPTI-FREE RepleniSH multipurpose solution
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Massachusetts Eye and Ear InfirmaryUniversity of Iowa; Alcon ResearchCompletedRefractive Error | MyopiaUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Abbott Medical OpticsCompletedNormal Contact Lens WearersCanada
-
Bausch & Lomb IncorporatedCompletedAdverse Effect of Contact Lens SolutionMalaysia
-
Southern California College of Optometry at Marshall...Alcon ResearchCompletedContact Lens Disinfecting SolutionsUnited States
-
Alcon ResearchCompletedContact Lens Wear